Metabonomic assessment of liver fibrosis in chronic hepatitis C (Metabonomic)
1st February 2010
Team: Professor Neil Guha.
Funded by Pfizer and NIHR ( 2010 to 2013)
The platform technology of metabonomics provides an opportunity to develop novel non-invasive biomarkers of liver fibrosis. This research is a collaboration between Nottingham, Southampton and Imperial College London. In patients undergoing liver biopsy we are collecting blood tests to determine if low molecular weight metabolites can predict the degree of liver scarring.
|Professor Neil Guha||Dr Neil Guha is a Clinical Associate Professor in Hepatology at the University of Nottingham. He trained at Guy's and St. Thomas's hospitals and began his postgraduate career in hepatology at St. Mary's Hospital, London. His doctoral thesis, awarded by…|